Leaflet ZEVALIN 1.6mg / ml kit

Product code:
W42167001
Quantity:
1
Indicated for:
lymphoma
Route of administration:
injectable
Substance:
ibritumomab tiuxetan (monoclonal antibody)
ATC
V10XX02 — Various | Other therapeutic radiopharmaceuticals | Various therapeutic radiopharmaceuticals

Precautions:

Anaphylaxis

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring

Additional monitoring

This medicine is subject to additional monitoring.

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Ibritumomab tiuxetan is a radioactive monoclonal antibody used for the treatment of non-Hodgkin's lymphoma. It works by binding to the CD20 antigen on the surface of B-lymphocytes, destroying cancer cells through radiation and immune mechanisms.

The medication is administered intravenously, as directed by a doctor, and requires careful monitoring for adverse effects.

Side effects may include nausea, fever, fatigue, decreased blood cell counts, or allergic reactions. In rare cases, severe infections or tumor lysis syndrome may occur.

Ibritumomab tiuxetan is not recommended for patients with hypersensitivity to this medication or active severe infections.

General data about ZEVALIN 1.6mg / ml

Substance:
ibritumomab tiuxetan
Date of latest medicines list:
01-07-2013
Product code:
W42167001
Concentration:
1.6mg / ml
Pharmaceutical form:
kit
Quantity:
1
Product type:
Original
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.